Héloïse Ifergan1, Thomas Perus2, Kevin Janot2, Basile Kerleroux2, Jonathan Ifergan3, Richard Bibi2, Henri Marret4, Grégoire Boulouis2, Henri Azaïs5, Denis Herbreteau2. 1. Department of Diagnostic and Interventional Neuroradiology, Bretonneau Hospital, University of Tours, Tours, France. ifergan.heloise@hotmail.fr. 2. Department of Diagnostic and Interventional Neuroradiology, Bretonneau Hospital, University of Tours, Tours, France. 3. Department of Radiology, Alleray Labrouste Clinic, Paris, France. 4. Department of Obstetrics, Gynecology and Reproductive Medicine, University Hospital of Tours, Tours, France. 5. Department of Gynecologic and Breast Oncological Surgery, Georges-Pompidou European Hospital, APHP. Centre, Paris, France.
Abstract
PURPOSE: In patients with persisting symptoms after uterine arteries embolization (UAE), ovarian arteries embolization (OAE) may play a role to improve symptoms and decrease subsequent surgery rates. In a retrospective cohort, we aimed to investigate the efficacy and safety of OAE in females with recurrent or persistent symptoms following UAE. METHODS: We performed a retrospective analysis of prospectively collected cases at a single reference academic hospital; we identified patients who benefited from OAE for persisting symptoms following UAE from 2008 to 2021. Outcome variables included the rates of subsequent surgery, a quality-of-life questionnaire with the UFS-QOL tool, the MRI reduction in uterine and fibroids volumes and the fibroid devascularization rate. RESULTS: Among 1300 women treated with UAE during the study period, 18 eventually received OAE and were included (mean age 44 ± 4.3 SD). There was no OAE procedural complication. There was a decrease in uterine volume and a complete devascularization of the dominant fibroid in 10/11 (90.9%) patients who underwent 12 months MRI. Three women underwent subsequent hysterectomy. Among 10/18 patients who answered the quality-of-life questionnaire after a mean follow-up of 70 months, eight reported an improvement or stability of symptoms. CONCLUSION: OAE for persisting symptoms after UAE was associated with improvement or stability of quality-of-life in most study subjects and less than a fifth of the cohort underwent hysterectomy after OAE. This study highlights the role of OAE as an adjunct to UAE.
PURPOSE: In patients with persisting symptoms after uterine arteries embolization (UAE), ovarian arteries embolization (OAE) may play a role to improve symptoms and decrease subsequent surgery rates. In a retrospective cohort, we aimed to investigate the efficacy and safety of OAE in females with recurrent or persistent symptoms following UAE. METHODS: We performed a retrospective analysis of prospectively collected cases at a single reference academic hospital; we identified patients who benefited from OAE for persisting symptoms following UAE from 2008 to 2021. Outcome variables included the rates of subsequent surgery, a quality-of-life questionnaire with the UFS-QOL tool, the MRI reduction in uterine and fibroids volumes and the fibroid devascularization rate. RESULTS: Among 1300 women treated with UAE during the study period, 18 eventually received OAE and were included (mean age 44 ± 4.3 SD). There was no OAE procedural complication. There was a decrease in uterine volume and a complete devascularization of the dominant fibroid in 10/11 (90.9%) patients who underwent 12 months MRI. Three women underwent subsequent hysterectomy. Among 10/18 patients who answered the quality-of-life questionnaire after a mean follow-up of 70 months, eight reported an improvement or stability of symptoms. CONCLUSION: OAE for persisting symptoms after UAE was associated with improvement or stability of quality-of-life in most study subjects and less than a fifth of the cohort underwent hysterectomy after OAE. This study highlights the role of OAE as an adjunct to UAE.
Authors: Scott C Goodwin; James B Spies; Robert Worthington-Kirsch; Eric Peterson; Gaylene Pron; Shuang Li; Evan R Myers Journal: Obstet Gynecol Date: 2008-01 Impact factor: 7.661
Authors: Gloria M M Salazar; T Gregory Walker; Raymond F Conway; Kalpana Yeddula; Stephan Wicky; Arthur C Waltman; Sanjeeva P Kalva Journal: J Vasc Interv Radiol Date: 2013-07-18 Impact factor: 3.464
Authors: Isaac Manyonda; Anna-Maria Belli; Mary-Ann Lumsden; Jonathan Moss; William McKinnon; Lee J Middleton; Versha Cheed; Olivia Wu; Fusun Sirkeci; Jane P Daniels; Klim McPherson Journal: N Engl J Med Date: 2020-07-30 Impact factor: 91.245